Report : North America IVD Contract Research Organization Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type (Clinical Chemistry, Molecular Diagnostics, Immunochemistry, Companion Diagnostics, Hematology, Histology and Cytology, Microbiology, and Others), and Services (Clinical Research, Biostatistics and Data Management Services, Therapeutic Expertise, Regulatory Services, Reimbursement Services, Assay Development Services, and Others)

Clinical Chemistry Segment to Dominate North America IVD Contract Research Organization Market during 2019–2028
  
According to a new market research study on “North America IVD Contract Research Organization Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type and Services,” is expected to reach US$ 3,213.78 million by 2028 from US$ 1,882.10 million in 2021. The market is estimated to grow at a CAGR of 7.9% from 2021 to 2028. Increasing demand for in-vitro diagnostics and increase in clinical trials is the major factor driving the growth of the North America IVD contract research organization market. However, stringent government policies and lack of skilled workforce may hinder the growth of North America IVD contract research organization market. The report provides trends prevailing in the North America IVD contract research organization market along with the drivers and restraints pertaining to the market growth.

The North America IVD contract research organization market is segmented into type, services, and country. The North America IVD contract research organization market, by type, is segmented into clinical chemistry, molecular diagnostics, immunochemistry, companion diagnostics, hematology, histology and cytology, microbiology, and others. The clinical chemistry segment held the largest share of the market in 2020. The North America IVD contract research organization market, by services, is segmented into clinical research, biostatistics and data management services, therapeutic expertise, regulatory services, reimbursement services, assay development services, and others. The biostatistics and data management services segment held the largest share of the market in 2020. Similarly, based on country, the North America IVD contract research organization market is segmented into the US, Canada, and Mexico. The US contributed a substantial share in 2020.  

CMIC HOLDINGS CO., LTD; DCN Dx; ICON PLC; NAMSA; Nexelis, a Q² Solutions Company; Proxima Clinical Research, Inc.; ResearchDx; and Toolbox Medical Innovations are among the leading companies in the North America IVD contract research organization market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2020, ICON plc, launched Accellacare a global clinical research network offering patients easier and faster access to creative treatments and offering customers the option to deploy decentralized trials.

Contact Us

Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com
 

Download Free PDF Brochure